Researchers at the Helmholtz Centre for Infection Research (HZI) have developed a promising new vaccine technology. Their studies to date show that just one dose of vaccine leads to effective and long-lasting immune...
The interdisciplinary project DEFENDER is developing innovative approaches to combat (re-)emerging viruses. The project, coordinated by the Leibniz Institute of Virology (LIV), is being funded with around eight 9.6...
A research team from the Helmholtz Institute for One Health (HIOH) has investigated the distribution and characteristics of multidrug-resistant bacteria in the Baltic Sea. The findings prove that resistant pathogens...
Global migration has increased in recent decades due to war, conflict, persecutions, and natural disasters, but also secondary to increased opportunities related to work or study. A group of international experts that...
Microorganisms produce a wide variety of natural products that can be used as active ingredients to treat diseases such as infections or cancer. The blueprints for these molecules can be found in the microbes' genes,...
In April 2024, the Helmholtz Centre for Infection Research (HZI) completely revamped its website together with the digital agency +Pluswerk. The aim of this relaunch was to present the HZI and its scientific work to the...
When women are pregnant and nurse their babies, their bodies change and various organs, such as the breasts or the immune system, are adapted to ensure the health of both mother and child. This happens throughout...
On 29 November 2024, a matchmaking workshop between scientists of the Helmholtz Centre for Infection Research (HZI) and the Centre for Structural Systems Biology (CSSB) in Hamburg was held at the HZI campus in...
A conversation with Prof. Andreas Keller from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Prof. Yang Li from the Centre for Individualised Infection Medicine (CiiM) about artificial...
